Prabhat Prakash News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prabhat prakash. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prabhat Prakash Today - Breaking & Trending Today

Reasoning behind experimental booster shots

Studies have shown a reduction in the efficacy of vaccines with newer variants. As the world moves towards boosters doses, the efficacy of the COVID vaccines is becoming a concern. According to researchers from the University of Oxford, UK, and the country’s Office for National Statistics, Pfizer/BioNTechCOVID-19 vaccine efficacy fell to 90 per cent, 85 per cent, and 78 per cent after 30, 60, and 90 days, respectively, and AstraZeneca vaccine efficacy dropped to 61 per cent by 90 days with the Delta variant. There are ongoing studies for booster doses but certain governments and vaccine manufactures have advocated for booster doses. Booster doses can become a burden for nations when some are struggling to obtain vaccines for first and second doses. ....

United States , United Kingdom , Cyrus Poonawalla , Priya Abraham , Zydus Cadila Zyco , Soumya Swaminathan , Tedros Adhanom Ghebreyesus , Prabhat Prakash , Winnie Byanyima , Narendra Modi , Adar Poonawalla , Kiran Majumdar Shaw , Anna Marriott , Serum Institute Life Sciences , Biocon Biologics Ltd , National Institute Of Virology , University Of Oxford , Bureau Of Investigative Journalism , Indian Council Of Medical Research , Serum Institute India Covisheild , World Health Organisation , People Vaccine Alliance , Office For National Statistics Pfizer Biontech , Serum Institute Of India , Prime Minister Narendra Modi , Drug Controller General ,